Karolinska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

1991

  1. Steady‐state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of age

    Journal of Internal Medicine, Vol. 229, Núm. 3, pp. 247-251

1990

  1. D-Propoxyphene is a potent inhibitor of debrisoquine, but not S-Mephenytoin 4-hydroxylation in vivo

    Therapeutic Drug Monitoring, Vol. 12, Núm. 3, pp. 297-299

  2. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide [see comments]

    British Journal of Clinical Pharmacology, Vol. 29, Núm. 2, pp. 215-219

1989

  1. Diazepam treatment does not influence the debrisoquine or mephenytoin hydroxylation phenotyping tests

    Therapeutic Drug Monitoring, Vol. 11, Núm. 6, pp. 721-723

  2. Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype

    Clinical Pharmacology and Therapeutics, Vol. 45, Núm. 4, pp. 348-355

  3. Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden

    European Journal of Clinical Pharmacology, Vol. 37, Núm. 1, pp. 65-68

  4. S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin

    Clinical Pharmacology and Therapeutics, Vol. 45, Núm. 5, pp. 495-499